Integra Lifesciences Holdings Income Statement (2009-2026) | IART

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	389.99M	386.86M	405.52M	376.64M	397.81M	385.19M	398.02M	380.85M	381.27M	382.42M	397.04M	368.87M	418.18M	380.83M	442.65M	382.65M	415.61M	402.06M	434.93M	391.92M
Cost of Revenue (Quarter)	151.27M	144.47M	156.25M	142.57M	148.40M	148.44M	147.94M	147.97M	174.24M	164.08M	170.55M	162.04M	192.26M	180.60M	193.57M	188.22M	206.27M	195.07M	214.06M	174.94M
Gross Profit (Quarter)	238.72M	242.39M	249.27M	234.07M	249.41M	236.75M	250.09M	232.87M	207.03M	218.34M	226.49M	206.83M	225.92M	200.24M	249.07M	194.43M	209.33M	206.99M	220.87M	216.98M
Operating items
Amortization - Intangibles (Quarter)	4.20M	4.11M	4.08M	3.89M	3.30M	3.14M	3.54M	3.11M	3.03M	3.21M	3.03M	10.11M	3.71M	3.76M	3.71M	3.70M	3.75M	3.73M	3.77M	3.78M
Research & Development (Quarter)	20.12M	25.83M	24.73M	24.09M	25.59M	24.74M	26.78M	26.72M	26.59M	26.60M	24.28M	26.96M	29.77M	27.43M	31.21M	24.73M	27.00M	22.46M	24.79M	23.50M
Selling, General & Administrative (Quarter)	162.55M	156.01M	162.25M	159.93M	160.65M	143.82M	151.92M	166.66M	164.91M	161.95M	163.13M	165.80M	195.47M	177.19M	178.52M	181.50M	179.89M	169.05M	169.27M	178.24M
Other Operating Expenses (Quarter)	-0.68M	-0.23M	-0.17M			0.64M		151.08M	177.27M			172.15M	195.97M	184.36M	197.29M	191.93M	721.39M	198.80M	217.83M	178.71M
Operating Expenses (Quarter)	338.14M	330.42M	347.30M	330.47M	337.95M	320.14M	330.18M	344.46M	368.76M	355.83M	360.99M	364.91M	421.20M	388.98M	407.02M	398.15M	928.28M	390.30M	411.88M	380.45M
Operating Income (Quarter)	51.85M	56.44M	58.22M	46.16M	59.87M	65.05M	67.84M	36.38M	12.50M	26.59M	36.05M	3.96M	-3.03M	-8.15M	35.63M	-15.50M	-512.67M	11.76M	23.04M	11.47M
EBIT (Quarter)	51.85M	56.44M	58.22M	46.16M	59.87M	65.05M	67.84M	36.38M	12.50M	26.59M	36.05M	3.96M	-3.03M	-8.15M	35.63M	-15.50M	-512.67M	11.76M	23.04M	11.47M
Non-operating items
Interest & Investment Income (Quarter)	1.76M	1.79M	1.44M	1.38M	1.97M	3.26M	5.31M	4.11M	3.94M	4.61M	4.55M	5.04M	5.06M	5.05M	4.89M	4.42M	4.71M	4.98M	4.36M	4.11M
Other Non Operating Income (Quarter)	5.03M	4.99M	4.42M	3.43M	1.98M	2.65M	3.95M	1.39M	-0.15M	0.47M	2.01M	-0.61M	1.44M	2.11M	1.00M	-0.14M	-1.95M	-0.84M	0.58M	4.48M
Non Operating Income (Quarter)	5.03M	4.99M	4.42M	3.43M	1.98M	2.65M	3.95M	1.39M	-0.15M	0.47M	2.01M	-0.61M	1.44M	2.11M	1.00M	-0.14M	-1.95M	-0.84M	0.58M	4.48M
Net income details
EBT (Quarter)	44.82M	50.79M	51.79M	39.31M	51.58M	58.80M	64.21M	29.78M	3.82M	18.61M	28.86M	-5.23M	-15.19M	-20.36M	22.54M	-30.04M	-530.95M	-6.82M	4.31M	-2.41M
Tax Provisions (Quarter)	9.76M	7.56M	6.40M	6.41M	6.79M	8.88M	11.26M	5.55M	-0.36M	-0.89M	9.02M	-1.95M	-2.78M	-9.67M	3.11M	-4.74M	-46.88M	-1.42M	6.01M	2.21M
Profit After Tax (Quarter)	35.07M	43.23M	45.38M	32.90M	44.79M	49.91M	52.95M	24.23M	4.18M	19.50M	19.83M	-3.28M	-12.40M	-10.70M	19.43M	-25.29M	-484.07M	-5.40M	-1.70M	-4.62M
Income from Continuing Operations (Quarter)	35.07M	43.23M	45.38M	32.90M	44.79M	49.91M	52.95M	24.23M	4.18M	19.50M	19.83M	-3.28M	-12.40M	-10.70M	19.43M	-25.29M	-484.07M	-5.40M	-1.70M	-4.62M
Consolidated Net Income (Quarter)	35.07M	43.23M	45.38M	32.90M	44.79M	49.91M	52.95M	24.23M	4.18M	19.50M	19.83M	-3.28M	-12.40M	-10.70M	19.43M	-25.29M	-484.07M	-5.40M	-1.70M	-4.62M
Income towards Parent Company (Quarter)	35.07M	43.23M	45.38M	32.90M	44.79M	49.91M	52.95M	24.23M	4.18M	19.50M	19.83M	-3.28M	-12.40M	-10.70M	19.43M	-25.29M	-484.07M	-5.40M	-1.70M	-4.62M
Net Income towards Common Stockholders (Quarter)	35.07M	43.23M	45.38M	32.90M	44.79M	49.91M	52.95M	24.23M	4.18M	19.50M	19.83M	-3.28M	-12.40M	-10.70M	19.43M	-25.29M	-484.07M	-5.40M	-1.70M	-4.62M
Additional items
EPS (Basic) (Quarter)	0.41	0.51	0.54	0.39	0.54	0.60	0.64	0.30	0.05	0.24	0.26	-0.04	-0.16	-0.14	0.25	-0.33	-6.31	-0.07	-0.02	-0.06
EPS (Weighted Average and Diluted) (Quarter)	0.41	0.51	0.53	0.39	0.54	0.60	0.63	0.29	0.05	0.24	0.25	-0.04	-0.16	-0.14	0.25	-0.33	-6.31	-0.07	-0.02	-0.06
Shares Outstanding (Weighted Average) (Quarter)	84.69M	84.75M	84.70M	83.63M	83.40M	82.95M	83.00M	81.87M	81.42M	80.84M	80.09M	77.73M	77.41M	77.20M	77.01M	76.46M	76.69M	76.75M	76.67M	76.95M
Shares Outstanding (Diluted Average) (Quarter)	85.34M	85.45M	85.48M	84.28M	83.62M	83.48M	83.52M	82.32M	81.74M	79.81M	80.34M	77.73M	77.41M	76.45M	77.01M	76.46M	76.58M	76.75M	76.67M	76.95M
EBITDA (Quarter)	28.73M	46.42M	58.22M	57.03M	52.60M	55.69M	67.84M	21.03M	1.95M	16.41M	36.05M	1.18M	-20.48M	-16.82M	35.63M	-21.83M	-490.87M	-6.47M	23.04M	-5.48M
Interest Expenses (Quarter)	13.15M	12.19M	12.12M	11.65M	12.24M	12.81M	12.89M	12.10M	12.46M	13.06M	13.75M	13.62M	18.65M	19.37M	18.98M	18.82M	21.04M	22.73M	23.67M	22.46M
Tax Rate (Quarter)	21.77%	14.88%	12.36%	16.31%	13.16%	15.10%	17.54%	18.64%	-9.41%	-4.77%	31.27%	37.27%	18.33%	47.48%	13.78%	15.79%	8.83%	20.81%	139.54%	-91.66%

Research Tools

Developers

Integra Lifesciences Holdings Income Statement (2009-2026) | IART

Research Tools

Developers

Integra Lifesciences Holdings Income Statement (2009-2026) | IART

Create an account

Sign In

Reset Password